ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries business update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Sun Pharma's drug UNLOXCYT received Category 2A preferred designation in updated NCCN guidelines for treating locally advanced cutaneous squamous cell carcinoma.
Sun Pharma reported positive two-year clinical data for its LEQSELVI alopecia areata treatment, presented at the 2026 EADV Congress, highlighting sustained safety and efficacy.
Sun Pharma attended a White House signing ceremony, committing to Most Favored Nation pricing for U.S. Medicaid programs and future innovative medicine launches.